1. STAT Protein Thermal Shift Assays to Monitor Protein‐Inhibitor Interactions. (5th July 2022) Authors: Iliev, Petar; Hanke, Danielle; Page, Brent D. G. Journal: Chembiochem Issue: Volume 23:Number 20(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. STAT3 activity is necessary and sufficient for the development of immune‐mediated myocarditis in mice and promotes progression to dilated cardiomyopathy. Issue 4 (5th March 2013) Authors: Camporeale, Annalisa; Marino, Francesca; Papageorgiou, Anna; Carai, Paolo; Fornero, Sara; Fletcher, Steven; Page, Brent D. G.; Gunning, Patrick; Forni, Marco; Chiarle, Roberto; Morello, Mara; Jensen, Ole; Levi, Renzo; Heymans, Stephane; Poli, Valeria Journal: EMBO molecular medicine Issue: Volume 5:Issue 4(2013:Apr.) Page Start: 572 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway. Issue 11 (1st November 2016) Authors: Belton, Amy; Xian, Lingling; Huso, Tait; Koo, Michael; Luo, Li Z.; Turkson, James; Page, Brent D. G.; Gunning, Patrick T.; Liu, Guosheng; Huso, David L.; Resar, Linda M. S. Journal: Leukemia & lymphoma Issue: Volume 57:Issue 11(2016:Nov.) Page Start: 2681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗